Fulcrum Therapeutics, Inc. - Common Stock —— 现金流量表 (NASDAQ:FULC) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -53.66 M-78.48 M-97.05 M-90.97 M-2.22 M-60.06 M -63.56 M 投资活动产生的现金 -57.14 M-129.67 M12.41 M-36.69 M32.23 M30.72 M -96.71 M 融资活动产生的现金 71.13 M186.51 M84.32 M118.12 M2.75 M168.67 M 168.35 M 自由现金流 -53.66 M-78.48 M-97.05 M-90.97 M-2.22 M-60.06 M -63.56 M

新闻

After Plunging 21.5% in 4 Weeks, Here's Why the Trend Might Reverse for Fulcrum Therapeutics (FULC)

Agios Rallies On A Surprise FDA Move In Sickle Cell, Pulling Rival Fulcrum Higher

Fulcrum Therapeutics在Leerink会议上聚焦镰状细胞病战略

Fulcrum Therapeutics at Leerink Conference: Strategic Focus on Sickle Cell

Stifel称Ipsen撤药可能给Fulcrum Therapeutics股价带来压力

Fulcrum Therapeutics stock may face pressure on Ipsen withdrawal, Stifel says

Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)

Fulcrum Therapeutics股价下跌,镰状细胞病试验未达目标

Fulcrum Therapeutics stock falls as sickle cell trial misses target

Leerink重申Fulcrum Therapeutics股票评级,基于镰状细胞病数据

Leerink reiterates Fulcrum Therapeutics stock rating on SCD data

美国银行重申Fulcrum Therapeutics股票评级为跑输大盘,目标价7美元